INTERNATIONAL PATENT: BIOKIER INC. FILES APPLICATION FOR "TREATMENT WITH COLON TARGETED BUTYRATE FOR REDUCTION OF TRIMETHYLAMINE N-OXIDE"

GENEVA, May 6 -- BIOKIER INC. (105 Green Willow CourtChapel Hill, NC 27514) filed a patent application (PCT/US2024/052475) for "TREATMENT WITH COLON TARGETED BUTYRATE FOR REDUCTION OF TRIMETHYLAMINE N-OXIDE" on Oct 23, 2024. With publication no. WO/2025/090548, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SZEWCZYK, Jerzy Ryszard (105 Green Willow CourtChapel Hill, NC 27514)

Abstract: Treatment of a person with TMAO over 6.2 micromolar with a colon targeted butyrate composition can lower TMAO below 6.2 micromolar ...